Literature DB >> 2231034

Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis.

H J Biem1, A S Detsky, P W Armstrong.   

Abstract

STUDY
OBJECTIVE: To determine the optimal strategy for the timing of aortic valve replacement in patients with chronic, severe aortic regurgitation with left ventricular dysfunction.
DESIGN: Decision analysis comparing early surgery (timed at the onset of left ventricular dysfunction) with delayed surgery (timed at the onset of symptoms) using data from the literature and expert opinion for variables in a representative case scenario (40-year-old man with bicuspid aortic valve disease).
SETTING: Tertiary care center doing valve replacement surgery.
MEASUREMENTS AND MAIN RESULTS: The early-surgery approach was preferred based on quality-adjusted life years. Sensitivity analysis showed that the result was not affected by the following variables within their derived ranges: rate of symptom development after onset of left ventricular dysfunction for the delayed-surgery approach, perioperative mortality for both approaches, and occurrence of major nonfatal stroke or congestive heart failure for both approaches. Although the decision was sensitive to the yearly postoperative mortality rates, the delayed-surgery operative mortality rate had to be almost as low as the early-surgery rate to change the preference to the delayed-surgery approach. The preference could also change if survival were much more important to the patient in the first five years than after five years or if the patient disliked living on anticoagulants enough to value a year on anticoagulants as worth only 80% of a year not on anticoagulants.
CONCLUSION: This decision analysis provides quantitative support for the impression that patients similar to the case scenario do better with surgery timed at the onset of ventricular dysfunction than with surgery delayed until symptoms develop. It thus supports the practice of following these patients noninvasively in order to time surgery.

Entities:  

Mesh:

Year:  1990        PMID: 2231034     DOI: 10.1007/bf02599423

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

1.  Thirteen year experience with aortic valve replacement.

Authors:  J W Rubin; H V Moore; R F Hillson; R G Ellison
Journal:  Am J Cardiol       Date:  1977-09       Impact factor: 2.778

2.  DEALE-ing with life expectancy and mortality rates.

Authors:  L J Stalpers; H J Van Gasteren; W A Van Daal
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

Review 3.  Decision analysis.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1987-01-29       Impact factor: 91.245

4.  Valve replacement for aortic regurgitation: long-term follow-up with factors influencing the results.

Authors:  D A Samuels; G D Curfman; A L Friedlich; M J Buckley; W G Austen
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

Review 5.  Chronic aortic regurgitation: indications for operation--1988.

Authors:  R A Nishimura; M D McGoon; H V Schaff; E R Giuliani
Journal:  Mayo Clin Proc       Date:  1988-03       Impact factor: 7.616

6.  A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

Authors:  J R Beck; J P Kassirer; S G Pauker
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

7.  Echocardiography in chronic aortic insufficiency. Is valve replacement too late when left ventricular end-systolic dimension reaches 55 mm?

Authors:  P Fioretti; J Roelandt; R J Bos; R S Meltzer; D van Hoogenhuijze; P W Serruys; J Nauta; P G Hugenholtz
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

8.  Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients.

Authors:  W L Henry; R O Bonow; J S Borer; J H Ware; K M Kent; D R Redwood; C L McIntosh; A G Morrow; S E Epstein
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

9.  Serial M-mode echocardiography in severe chronic aortic regurgitation.

Authors:  I G McDonald; V M Jelinek
Journal:  Circulation       Date:  1980-12       Impact factor: 29.690

10.  Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow?

Authors:  J Tsevat; M H Eckman; R A McNutt; S G Pauker
Journal:  Med Decis Making       Date:  1989 Jul-Sep       Impact factor: 2.583

View more
  3 in total

1.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Decision making in the management of asymptomatic patients with aortic regurgitation: a cardiologist's perspective.

Authors:  C M Otto
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

3.  The meaning of life expectancy: what is a clinically significant gain?

Authors:  D Naimark; G Naglie; A S Detsky
Journal:  J Gen Intern Med       Date:  1994-12       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.